Position in IVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,593,231
-$1,214,291 QoQ
Shares Held
686,040
0.0% QoQ
Ownership
0.290%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#39
of 88 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in IVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BVF INC/IL holds $3,440,293,274 across 41 Biotechnology names. IVA ranks #39 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,965,160 | $555,315,164 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
3,872,052 | $444,008,202 | |
| 3 | MLTX |
MoonLake Immunotherapeutics
|
16,001,284 | $311,544,999 | |
| 4 | GHRS |
GH Research PLC
|
8,650,158 | $232,516,247 | |
| 5 | GPCR |
Structure Therapeutics Inc.
|
3,366,823 | $180,697,390 | |
| 6 | NKTR |
Nektar Therapeutics
|
2,391,075 | $166,920,945 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,056,027 | $123,629,080 | |
| 8 | XNCR |
Xencor Inc
|
7,133,720 | $114,852,892 |
All Filings in IVA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,593,231 | 686,040 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,807,522 | 686,040 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,190,086 | 686,040 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,972,171 | 686,040 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,188,467 | 686,040 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,016,957 | 686,040 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,468,125 | 686,040 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,279,464 | 686,040 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,051,259 | 686,040 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,483,464 | 686,040 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,098,156 | 686,040 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,881,368 | 686,040 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,771,601 | 686,040 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,497,185 | 686,040 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,059,738 | 686,040 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,698,195 | 686,040 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,889,846 | 686,040 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,820,856 | 686,040 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,437,870 | 544,500 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,710,120 | 544,500 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,458,945 | 107,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,572,900 | 107,000 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||